ArticleCellular oncology (Dordrecht, Netherlands)2023

TRIM17-mediated ubiquitination and degradation of RBM38 promotes cisplatin resistance in non-small cell lung cancer.

Tian Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.